企业QQ
官方微信
| 211-11A | Recombinant Murine IL-1a | Peprotech | 2ug/10ug/ | 支 |
| 211-11B | Recombinant Murine IL-1β | Peprotech | 2ug/10ug/ | 支 |
| 212-12 | Recombinant Murine IL-2 | Peprotech | 5ug/20ug/ | 支 |
| 213-13 | Recombinant Murine IL-3 | Peprotech | 2ug/10ug/ | 支 |
| 214-14 | Recombinant Murine IL-4 | Peprotech | 2ug/10ug/ | 支 |
| 216-16 | Recombinant Murine IL-6 | Peprotech | 5ug/20ug/ | 支 |
| 220-11 | Recombinant Murine IL-11 | Peprotech | 2ug/10ug/ | 支 |
| 250-05 | Recombinant Murine G-CSF | Peprotech | 2ug/10ug/ | 支 |
| 250-19 | Recombinant Murine IGF-1 | Peprotech | 10ug/50ug/ | 支 |
| 300-01A | Recombinant Human TNF-a | Peprotech | 10ug/50ug/ | 支 |
| 300-02 | Recombinant Human IFN-r | Peprotech | 20ug/100ug/ | 支 |
| 300-03 | Recombinant Human GM-CSF | Peprotech | 10ug/1mg/ | 支 |
| 300-03 | Recombinant Human GM-CSF | Peprotech | 2ug/10ug/ | 支 |
| 300-23 | Recombinant Human G-CSF | Peprotech | 2ug/10ug/ | 支 |
| 315-01a | Recombinant Murine TNF-a | Peprotech | 5ug/20ug/ | 支 |
| 315-03 | Recombinant Murine GM-CSF | Peprotech | 10ug/1mg/ | 支 |
| 315-03 | Recombinant Murine GM-CSF | Peprotech | 2ug/10ug/ | 支 |
| 315-05 | Recombinant Murine IFN-r | Peprotech | 20ug/100ug/ | 支 |
| 315-09 | Recombinant Murine EGF | Peprotech | 100ug/500ug/ | 支 |
| 450-01 | Recombinant Human beta-NGF | Peprotech | 5ug/20ug/ | 支 |
| 450-32 | Recombinant Murine VEGF | Peprotech | 2ug/10ug/ | 支 |
| 450-33 | Recombinant Murine FGF-basic | Peprotech | 10ug/50ug/ | 支 |
| 450-33A | Recombinant Murine FGF-acidic | Peprotech | 10ug/50ug/ | 支 |
| 450-34 | Recombinant Murine β-NGF | Peprotech | 5ug/20ug/ | 支 |
| CYT-201 | Recombinant Human EPO | Prospec | 5ug/50ug | 支 |
| CYT-204 | Recombinant Human IFN-α2a | Prospec | 20ug/100ug/ | 支 |
| CYT-205 | Recombinant Human IFN-α2b | Prospec | 20ug/100ug/ | 支 |
| Recombinant Human HGH | Prospec | 支 |